SSLNOSoleno Therapeutics Inc

Soleno Therapeutics Inc

SLNO

1D · 1W · 1M · 3M · YTD · 1Y · 5Y · AllLive SLNO chart

  • Mkt cap

    $2.76B

  • EV/Sales

    14.4

  • P/E ratio

    N/A

  • FY2025 Revenue

    $190.41M

  • EPS (FY2025)

    N/A

  • Gross Margin (FY2025)

    98.58%

  • Profit Margin (FY2025)

    10.97%

  • Beta

    N/A

  • Div yield

    N/A

  • Sector

    Healthcare

Live SLNO terminalLician Pro · $19.99/mo or $149/yrPeer financials on ProAPI free 100/dayCompare AAPL vs MSFT

SLNO — Soleno Therapeutics Inc · rev $190.4M

SLNO Key Statistics

  • Market Cap: $2.76B
  • P/B Ratio: 5.57

Soleno Therapeutics Inc latest statements (FY2025)

Latest cached year on this hub. Full SLNO income, balance, and cash tables.

  • Revenue$190.4M
  • Net Income$20.9M
  • Total Assets$563.8M
  • Total Debt$49.8M
  • Free Cash Flow$46.7M

† Total Debt: Derived from long-term debt only (no total or short-term debt stored).

SLNO recent filings

SLNO FAQ

What industry is SLNO in?

Soleno Therapeutics Inc (SLNO) is a biotechnology company in the Healthcare sector.

What are SLNO's latest revenue and net income?

Latest cached Soleno Therapeutics Inc (SLNO) revenue for Dec 31, 2025 was $190.4M. Net income was $20.9M. Statements: https://lician.com/financials/slno

What is SLNO's market cap?

Soleno Therapeutics Inc (SLNO) market capitalization is $2.76B on the latest cached snapshot.

What is the latest SLNO SEC filing?

The latest cached SLNO filing is 8-K · Jan 12, 2026. Filings: https://lician.com/sec/slno

Live SLNO terminal loads when you scroll near this section.